Eyenovia Statistics
Total Valuation
Eyenovia has a market cap or net worth of $68.21 million. The enterprise value is $76.86 million.
| Market Cap | 68.21M |
| Enterprise Value | 76.86M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Eyenovia has 61.45 million shares outstanding. The number of shares has increased by 24.58% in one year.
| Shares Outstanding | 61.45M |
| Shares Change (YoY) | +24.58% |
| Shares Change (QoQ) | -3.79% |
| Owned by Insiders (%) | 15.74% |
| Owned by Institutions (%) | 14.46% |
| Float | 40.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7,768.29 |
| Forward PS | 11.39 |
| PB Ratio | 37.52 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8,754.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88, with a Debt / Equity ratio of 9.15.
| Current Ratio | 0.88 |
| Quick Ratio | 0.49 |
| Debt / Equity | 9.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.50 |
Financial Efficiency
Return on equity (ROE) is -349.60% and return on invested capital (ROIC) is -163.65%.
| Return on Equity (ROE) | -349.60% |
| Return on Assets (ROA) | -108.90% |
| Return on Capital (ROIC) | -163.65% |
| Revenue Per Employee | $154 |
| Profits Per Employee | -$569,190 |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.36% in the last 52 weeks. The beta is 1.78, so Eyenovia's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -52.36% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 66.39 |
| Average Volume (20 Days) | 1,110,840 |
Short Selling Information
The latest short interest is 3.93 million, so 6.39% of the outstanding shares have been sold short.
| Short Interest | 3.93M |
| Short Previous Month | 3.92M |
| Short % of Shares Out | 6.39% |
| Short % of Float | 9.72% |
| Short Ratio (days to cover) | 6.15 |
Income Statement
In the last 12 months, Eyenovia had revenue of $8,780 and -$32.44 million in losses. Loss per share was -$0.73.
| Revenue | 8,780 |
| Gross Profit | 17,560 |
| Operating Income | -30.20M |
| Pretax Income | -32.44M |
| Net Income | -32.44M |
| EBITDA | -29.01M |
| EBIT | -29.85M |
| Loss Per Share | -$0.73 |
Balance Sheet
The company has $7.98 million in cash and $16.63 million in debt, giving a net cash position of -$8.66 million or -$0.14 per share.
| Cash & Cash Equivalents | 7.98M |
| Total Debt | 16.63M |
| Net Cash | -8.66M |
| Net Cash Per Share | -$0.14 |
| Equity (Book Value) | 1.82M |
| Book Value Per Share | 0.03 |
| Working Capital | -2.01M |
Cash Flow
In the last 12 months, operating cash flow was -$26.77 million and capital expenditures -$3.25 million, giving a free cash flow of -$30.02 million.
| Operating Cash Flow | -26.77M |
| Capital Expenditures | -3.25M |
| Free Cash Flow | -30.02M |
| FCF Per Share | -$0.64 |
Margins
Gross margin is 200.00%, with operating and profit margins of -343,927.95% and -369,519.72%.
| Gross Margin | 200.00% |
| Operating Margin | -343,927.95% |
| Pretax Margin | -369,519.72% |
| Profit Margin | -369,519.72% |
| EBITDA Margin | -330,448.92% |
| EBIT Margin | -339,946.75% |
| FCF Margin | -341,869.79% |
Dividends & Yields
Eyenovia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.58% |
| Shareholder Yield | -24.58% |
| Earnings Yield | -47.57% |
| FCF Yield | -44.01% |
Analyst Forecast
The average price target for Eyenovia is $10.00, which is 800.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 800.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 681.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Eyenovia has an Altman Z-Score of -10.54 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.54 |
| Piotroski F-Score | 2 |